Lilly Recognized as One of the World's Top Biopharmaceutical Employers

Friday, October 10, 2008 General News J E 4
INDIANAPOLIS, Oct. 10 Eli Lilly and Company(NYSE: LLY) announced today that it has made the list of Top 20biopharmaceutical employers, according to the prestigious peer-reviewedjournal Science. Science's 2008 survey polled nearly 4,000 employees from 500employers in the biotechnology, biopharmaceutical, pharmaceutical and relatedindustries. This year Lilly ranks number 10 on the list, up one position fromlast year's survey.

"At Lilly, our mission is to deliver innovative medicines for some of theworld's most urgent unmet medical needs," said Steven Paul, M.D., executivevice president of science and technology, and president of Lilly ResearchLaboratories. "Core to our pipeline performance is the robust researchenvironment here at Lilly, including excellence in both basic scientific andclinical research. Our world-renowned scientific talent has allowed Lilly toestablish what we believe to be one of the best mid-stage pipelines in theindustry, including 50 unique medicines - an all-time high for the company."

The web-based survey aims to determine the most reputable employers in thelife science industries based on 23 characteristics, including among others,treating employees with respect, financial strength, easy adaptation tochange, and a research-driven environment. The survey results appeared intoday's issue of Science.

"It is an honor for Lilly to be recognized as one of the industry's topemployers based on these important criteria," said John Lechleiter, Ph.D.,Lilly president and chief executive officer. "Respect for people has alwaysbeen a core value of Eli Lilly and Company, and this acknowledgementunderscores Lilly's commitment to our employees and the patients we serve."

Approximately 25 percent of Lilly's 2007 sales came from biotechmedicines; this makes the biotech portion of the company's business theequivalent of the world's fifth largest biotech company. Biotech moleculesalso represent approximately one-third of the company's current pipelineincluding potential treatments targeting Alzheimer's disease, cancer anddiabetes.

About Science

Published by the American Association for the Advancement of Science(AAAS), Science ranks as the world's largest general science journal. Eachweek, Science provides more than 130,000 global subscribers with peer-reviewedoriginal research, scientific research articles, science and research news andmore. Science also produces a freely accessible careers website,, offering thousands of job listings, career advice andmore.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growingportfolio of first-in-class and best-in-class pharmaceutical products byapplying the latest research from its own worldwide laboratories and fromcollaborations with eminent scientific organizations. Headquartered inIndianapolis, Ind., Lilly provides answers - through medicines and information- for some of the world's most urgent medical needs. Additional informationabout Lilly is available at


(Logo: )

SOURCE Eli Lilly and Company


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
FDA Approves AstraZeneca's SEROQUEL XR(R) for the ...
TriReme Medical Inc. Receives CE Marking for Antar...